ArticleCureus2025
A Rare Case of Ketosis-Prone Type 2 Diabetes With a Unique Human Leukocyte Antigen (HLA) Profile: Genetic and Metabolic Insights.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This report describes the case of a 21-year-old man with ketosis-prone type 2 diabetes (KPD), highlighting the genetic and metabolic factors influencing disease progression. The patient presented with diabetic ketoacidosis and demonstrated rapid insulin secretory recovery, allowing early discontinuation of insulin. Genetic analysis revealed human leukocyte antigen (HLA)-DRB1*15:01 and DRB1*09:01 haplotypes, suggesting a role of immune factors typically associated with type 1 diabetes in the pathogenesis of KPD. Metabolic factors, evidenced by prolonged ketone clearance, further underscore the complexity of KPD. These findings contribute to a growing understanding of KPD as a unique subtype of diabetes, reinforcing the importance of personalized, genetically informed management approaches for optimal care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.